Remoção Precoce do Introdutor Arterial Após Intervenção Coronária Percutânea por Via Femoral: Estudo de Segurança e Eficácia

Zago, Gabriel; Trentin, Fabio; Prado Junior, Guy F. A; Spadaro, Andre Gasparini; Silva, Expedito Eustáquio Ribeiro da; Campos, Carlos Magalhães; Perin, Marco Antonio; Falcão, Breno de Alencar Araripe; Esteves-Filho, Antonio; Kajita, Luiz Junya; Gama, Marcus Nogueira da; Marchiori, Gilberto; Horta, Pedro Eduardo; Takimura, Celso Kiyochi; Mariani Junior, Jose; Galon, Micheli Zanotti; Soares, Paulo Rogerio; Zalc, Silvio; Kalil-Filho, Roberto; Lemos Neto, Pedro Alves.
Rev. bras. cardiol. invasiva ; 22(2): 149-154, Apr-Jun/2014. tab, graf
Artigo em Português | LILACS | ID: lil-722252

Documentos relacionados

  1. Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial.
  2. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass.
  3. Clinical Impact of Protamine Titration-Based Heparin Neutralization in Patients Undergoing Coronary Bypass Grafting Surgery.
  4. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro.
  5. Is 300 Seconds ACT Safe and Efficient during MiECC Procedures?
  6. Impact of omitting the intravenous heparin bolus on outcomes of leadless pacemaker implantation.
  7. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
  8. An ex vivo comparison of partial thromboplastin time and activated clotting time for heparin anticoagulation in an ovine model.
  9. [Evaluation of optimal dosage of heparin in hemodialysis patients by thromboelastograph].
  10. Heparin locks with low and high concentration in haemodialysis patients: A systematic review and meta-analysis.